Acorda Therapeutics Inc (NASDAQ:ACOR)

33.91
Delayed Data
As of Mar 30
 -0.29 / -0.85%
Today’s Change
28.26
Today|||52-Week Range
45.45
-17.03%
Year-to-Date

Today’s Trading

Previous close34.20
Today’s open34.63
Day’s range33.60 - 34.65
Volume446,609
Average volume (3 months)775,219
Market cap$1.5B
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-147.31%
Earnings growth (next 5 years)+15.50%
Revenue growth (last year)+19.34%
P/E ratio81.6
Price/Sales4.19
Price/Book2.65

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...+3.28+4.50%
NLNKNewLink Genetics Cor...+4.14+7.92%
USNAUSANA Health Science...+1.07+0.96%
CMRXChimerix Inc+0.85+2.29%
Data as of 03/30/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account